362 related articles for article (PubMed ID: 30797769)
1. Myeloperoxidase - A bridge linking inflammation and oxidative stress with cardiovascular disease.
Ndrepepa G
Clin Chim Acta; 2019 Jun; 493():36-51. PubMed ID: 30797769
[TBL] [Abstract][Full Text] [Related]
2. Myeloperoxidase As a Multifaceted Target for Cardiovascular Protection.
Ramachandra CJA; Ja KPMM; Chua J; Cong S; Shim W; Hausenloy DJ
Antioxid Redox Signal; 2020 May; 32(15):1135-1149. PubMed ID: 31847538
[No Abstract] [Full Text] [Related]
3. Myeloperoxidase: expressing inflammation and oxidative stress in cardiovascular disease.
Anatoliotakis N; Deftereos S; Bouras G; Giannopoulos G; Tsounis D; Angelidis C; Kaoukis A; Stefanadis C
Curr Top Med Chem; 2013; 13(2):115-38. PubMed ID: 23470074
[TBL] [Abstract][Full Text] [Related]
4. Inflammation and oxidative stress in ESRD--the role of myeloperoxidase.
Maruyama Y; Lindholm B; Stenvinkel P
J Nephrol; 2004; 17 Suppl 8():S72-6. PubMed ID: 15599890
[TBL] [Abstract][Full Text] [Related]
5. Neutrophil-derived myeloperoxidase promotes atherogenesis and neointima formation in mice.
Tiyerili V; Camara B; Becher MU; Schrickel JW; Lütjohann D; Mollenhauer M; Baldus S; Nickenig G; Andrié RP
Int J Cardiol; 2016 Feb; 204():29-36. PubMed ID: 26655530
[TBL] [Abstract][Full Text] [Related]
6. Association of the serum myeloperoxidase/high-density lipoprotein particle ratio and incident cardiovascular events in a multi-ethnic population: Observations from the Dallas Heart Study.
Khine HW; Teiber JF; Haley RW; Khera A; Ayers CR; Rohatgi A
Atherosclerosis; 2017 Aug; 263():156-162. PubMed ID: 28645072
[TBL] [Abstract][Full Text] [Related]
7. Myeloperoxidase: a useful biomarker for cardiovascular disease risk stratification?
Schindhelm RK; van der Zwan LP; Teerlink T; Scheffer PG
Clin Chem; 2009 Aug; 55(8):1462-70. PubMed ID: 19556446
[TBL] [Abstract][Full Text] [Related]
8. Synthetic Guaiacol Derivatives as Promising Myeloperoxidase Inhibitors Targeting Atherosclerotic Cardiovascular Disease.
Premkumar J; Sampath P; Sanjay R; Chandrakala A; Rajagopal D
ChemMedChem; 2020 Jul; 15(13):1187-1199. PubMed ID: 32368837
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Myeloperoxidase by
Yu G; Liang Y; Zheng S; Zhang H
J Pharmacol Exp Ther; 2018 Feb; 364(2):311-322. PubMed ID: 29255000
[TBL] [Abstract][Full Text] [Related]
10. Myeloperoxidase: a leukocyte-derived protagonist of inflammation and cardiovascular disease.
Nussbaum C; Klinke A; Adam M; Baldus S; Sperandio M
Antioxid Redox Signal; 2013 Feb; 18(6):692-713. PubMed ID: 22823200
[TBL] [Abstract][Full Text] [Related]
11. Myeloperoxidase enhances nitric oxide catabolism during myocardial ischemia and reperfusion.
Baldus S; Heitzer T; Eiserich JP; Lau D; Mollnau H; Ortak M; Petri S; Goldmann B; Duchstein HJ; Berger J; Helmchen U; Freeman BA; Meinertz T; Münzel T
Free Radic Biol Med; 2004 Sep; 37(6):902-11. PubMed ID: 15304260
[TBL] [Abstract][Full Text] [Related]
12. The other myeloperoxidase: Emerging functions.
Vanhamme L; Zouaoui Boudjeltia K; Van Antwerpen P; Delporte C
Arch Biochem Biophys; 2018 Jul; 649():1-14. PubMed ID: 29614255
[TBL] [Abstract][Full Text] [Related]
13. Emerging role of myeloperoxidase and oxidant stress markers in cardiovascular risk assessment.
Brennan ML; Hazen SL
Curr Opin Lipidol; 2003 Aug; 14(4):353-9. PubMed ID: 12865732
[TBL] [Abstract][Full Text] [Related]
14. Role of myeloperoxidase in cardiology.
Ikitimur B; Karadag B
Future Cardiol; 2010 Sep; 6(5):693-702. PubMed ID: 20932115
[TBL] [Abstract][Full Text] [Related]
15. Myeloperoxidase: A versatile mediator of endothelial dysfunction and therapeutic target during cardiovascular disease.
Maiocchi SL; Ku J; Thai T; Chan E; Rees MD; Thomas SR
Pharmacol Ther; 2021 May; 221():107711. PubMed ID: 33137376
[TBL] [Abstract][Full Text] [Related]
16. Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography.
Heslop CL; Frohlich JJ; Hill JS
J Am Coll Cardiol; 2010 Mar; 55(11):1102-9. PubMed ID: 20223364
[TBL] [Abstract][Full Text] [Related]
17. The development of myeloperoxidase inhibitors.
Galijasevic S
Bioorg Med Chem Lett; 2019 Jan; 29(1):1-7. PubMed ID: 30466896
[TBL] [Abstract][Full Text] [Related]
18. The roles of myeloperoxidase in coronary artery disease and its potential implication in plaque rupture.
Teng N; Maghzal GJ; Talib J; Rashid I; Lau AK; Stocker R
Redox Rep; 2017 Mar; 22(2):51-73. PubMed ID: 27884085
[TBL] [Abstract][Full Text] [Related]
19. Myeloperoxidase: Its role for host defense, inflammation, and neutrophil function.
Aratani Y
Arch Biochem Biophys; 2018 Feb; 640():47-52. PubMed ID: 29336940
[TBL] [Abstract][Full Text] [Related]
20. Myeloperoxidase Inhibitors as Potential Drugs.
Lazarević-Pasti T; Leskovac A; Vasić V
Curr Drug Metab; 2015; 16(3):168-90. PubMed ID: 26279325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
